A multicenter real-world study on the safety and effectiveness of the glucagon-like peptide-1 receptor agonist (liraglutide) in adolescents with obesity in Taiwan

Obesity Research & Clinical Practice · Elsevier

Аннотация

Publication date: September–October 2026 Source: Obesity Research & Clinical Practice, Volume 20, Issue 5 Author(s): Chiao-Fan Chiu, Chu-Kuang Chou, Shu-Wei Hu, Kuo-Chin Huang, Yi-Lei Wu, Hsiang-Fan Wu, Yang-Lin Liu, Yu-Chen Yang, Huey-Ling Chen, Chun-Yan Yeung

Читать у издателя →

Похожие статьи